Xponance, Inc. Senseonics Holdings, Inc. Transaction History

Xponance, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 23, 2023	BUY	$0.96 - $1.34 $1,271 - $1,774	1,324 Added 5.17%	26,916 $0
Q3 2022 Oct 24, 2022	BUY	$1.02 - $2.23 $763 - $1,670	749 Added 3.01%	25,592 $34,000
Q2 2022 Aug 02, 2022	BUY	$0.94 - $1.94 $4,035 - $8,328	4,293 Added 20.89%	24,843 $26,000
Q1 2022 Apr 20, 2022	BUY	$1.54 - $3.71 $291 - $701	189 Added 0.93%	20,550 $40,000
Q4 2021 Jan 31, 2022	BUY	$2.58 - $3.91 $56 - $86	22 Added 0.11%	20,361 $54,000
Q3 2021 Nov 05, 2021	SELL	$2.77 - $4.05 $6,667 - $9,748	-2,407 Reduced 10.58%	20,339 $69,000
Q2 2021 Aug 12, 2021	BUY	$1.71 - $4.14 $38,895 - $94,168	22,746 New	22,746 $87,000

136

60.1M

393K

254K

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $475M
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

Stay updated on Xponance, Inc. with notifications on news.